minor cannabinoid
CBG
Also known as: CannabigerolCannabigerol (CBG) is a non-intoxicating cannabinoid often called the “mother cannabinoid”: its acid form is the precursor the plant converts into THC, CBD, and others. Most cannabis contains it in small amounts.
Educational reference only — not medical advice. These statements have not been evaluated by the FDA, and this information is not intended to diagnose, treat, cure, or prevent any disease. Talk to a healthcare provider before use.
Typical dose
No established dose; human clinical data is limited. Products commonly pair CBG with CBD.
Onset
Sublingual 15–30 min · oral 30–90 min
Duration
Sublingual 4–6 h · oral 6–8 h
Legal status
Hemp-derived CBG (from plants ≤0.3% Delta-9 THC) is federally legal under the 2018 Farm Bill; state laws vary.
Common forms
Oil / tinctureCapsuleEdible
Safety
Considered generally well tolerated in the limited research to date; robust human safety data is not yet available. As with any cannabinoid, look for third-party testing.
Interactions
May share the liver-enzyme pathways other cannabinoids use; consult a healthcare provider if you take medication.
Who should avoid
People who are pregnant or nursing, or taking prescription medication, should consult a healthcare provider first.
Products with this
No listed products reference this yet.
Sources
- Nachnani R, et al. The Pharmacological Case for Cannabigerol. J Pharmacol Exp Ther. 2021.
- Agriculture Improvement Act of 2018 (Farm Bill), Pub. L. No. 115-334.